SUPERNUS PHARMACEUTICALS, INC. (SUPN) Total assets 2016–2025
SUPERNUS PHARMACEUTICALS, INC. (SUPN) total assets at each fiscal year-end, per SEC filings.
$1.5BFY2025 · since FY2016: $309.6M → $1.5B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.5B | +6.2% |
| FY2024 | $1.4B | +7.1% |
| FY2023 | $1.3B | -25.0% |
| FY2022 | $1.7B | +0.8% |
| FY2021 | $1.7B | +12.3% |
| FY2020 | $1.5B | +29.6% |
| FY2019 | $1.2B | +18.7% |
| FY2018 | $977.8M | +130.4% |
| FY2017 | $424.5M | +37.1% |
| FY2016 | $309.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SUPN financial trends
SUPN RevenueSUPN Net incomeSUPN Net marginSUPN Gross profitSUPN Gross marginSUPN Operating incomeSUPN Operating marginSUPN Operating cash flowSUPN Free cash flowSUPN Capital expendituresSUPN Return on equitySUPN Stock buybacksSUPN Dividends paidSUPN Total liabilitiesSUPN Shareholders’ equitySUPN overview →